2007Alcohol and AlcoholismOpen access

Oral Communication 12, Tuesday Sept. 25th 5.00 pm-6.00 pm; Room: Lecture Hall 3: Pharmacological approaches to addictive behaviour--Part 2

Author information unavailable

Open full text 0 citations

Abstract

Aims. Gamma-hydroxybutyric acid (GHB) is currently used in several European Countries, including Italy, for the treatment of alcohol dependence. It reduces alcohol drinking, promotes abstinence from alcohol, suppresses craving for alcohol, and ameliorates alcohol withdrawal syndrome. Consistently, administration of GHB has been found to suppress alcohol withdrawal signs and alcohol intake in rat models of alcohol dependence. The present study was designed to investigate whether GHB administration was capable of affecting alcohol's motivational properties (the possible animal correlate of human craving for alcohol) in selectively bred Sardinian alcohol-preferring (sP) rats.

Open-access reader

About this research paper

What this paper is about

Aims. Gamma-hydroxybutyric acid (GHB) is currently used in several European Countries, including Italy, for the treatment of alcohol dependence. It reduces alcohol drinking, promotes abstinence from alcohol, suppresses craving for alcohol, and ameliorates alcohol withdrawal syndrome. Consistently, administration of GHB has been found to suppress alcohol withdrawal signs and alcohol intake in rat models of alcohol dependence. The present study was designed to investigate whether GHB administration was capable of affecting alcohol's motivational properties (the possible animal correlate of human craving for alcohol) in selectively bred Sardinian alcohol-preferring (sP) rats.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aims. Gamma-hydroxybutyric acid (GHB) is currently used in several European Countries, including Italy, for the treatment of alcohol dependence. It reduces alcohol drinking, promotes abstinence from alcohol, suppresses craving for alcohol, and ameliorates alcohol withdrawal syndrome. Consistently, administration of GHB has been found to suppress alcohol withdrawal signs and alcohol intake in rat models of alcohol dependence. The present study was designed to investigate whether GHB administration was capable of affecting alcohol's motivational properties (the possible animal correlate of human craving for alcohol) in selectively bred Sardinian alcohol-preferring (sP) rats.

Key concepts: Alcohol, Craving, Abstinence, Alcohol addiction, Alcohol withdrawal syndrome, Alcohol dependence, Ethanol, Addiction

Related papers

Back to paper searchBrowse research topicsOriginal source
Oral Communication 12, Tuesday Sept. 25th 5.00 pm-6.00 pm; Room: Lecture Hall 3: Pharmacological approaches to addictive behaviour--Part 2 — Research Paper | ScholarLens